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Abstract
Diffuse intrinsic pontine glioma (DIPG) is one of the least understood and most
deadly childhood cancers. Historically, there has been a paucity of DIPG specimens
for molecular analysis. However, due to the generous participation of DIPG families
in programs for postmortem specimen donation, there has been a recent surge in
molecular analysis of newly available tumor specimens. Collaborative efforts to share
data and tumor specimens have resulted in rapid discoveries in other pediatric brain
tumors, such as medulloblastoma, and therefore have the potential to shed light on
the biology of DIPG. Given the generous gift of postmortem tissue donation from DIPG
patients, there is a need for standardized postmortem specimen accrual to facilitate
rapid and effective multi-institutional molecular studies.
We developed and implemented an autopsy protocol for rapid procurement,
documenting and storing these specimens. Sixteen autopsies were performed
throughout the United States and Canada and processed using a standard protocol
and inventory method, including specimen imaging, fixation, snap freezing, orthotopic
injection, or preservation. This allowed for comparative clinical and biological studies
of rare postmortem DIPG tissue specimens, generation of in vivo and in vitro models
of DIPG, and detailed records to facilitate collaborative analysis.

Introduction

disease has led to a paucity of specimens for molecular
studies. However, after decades of stagnation in the study
of DIPG biology there has been a recent surge in molecular
profiling of DIPG tumor tissue, resulting in identification
of novel mutations and genomic aberrations in this lethal
cancer [1-5]. One of the main factors contributing to this
expanding knowledge of DIPG biology is the selfless gift
from children with DIPG and their families of postmortem

Diffuse intrinsic pontine glioma (DIPG) is one of
the most poorly understood childhood cancers. Due to
the neuroanatomical location of DIPG and its infiltrative
nature, this tumor is not amenable to surgical resection.
The lack of readily available surgical specimens, coupled
with the progressive nature and high morbidity of this
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tumor donation for biological studies. However, despite
some efforts to implement a standardized autopsy protocol
for specimen acquisition [6], there is a continued need
to improve postmortem procurement procedures to
ensure optimized use of these precious specimens across
North America and Europe, particularly within DIPG
collaborative groups and consortia.
Here, we describe an autopsy protocol developed
at our institution that encompasses autopsy procedure
coordination and the acquisition, processing and storage
of frozen, fixed, and fresh tissue specimens for molecular
analyses, cell culture and orthotopic injection. We also
describe an alternative approach for cases in which
assistance with specimen procurement and processing
can be conducted in the absence of a trained pathologist.
We demonstrate that a standardized approach to specimen
acquisition and processing can facilitate identification and
characterization of tumor tissue, resulting in successful
generation of in vivo models of DIPG for further study.

subjects were approached by their neurooncologist for
possibility of specimen donation. Request for consent
to autopsy was made after radiation treatment when
the subjects had stable symptoms and disease burden.
A total of nine autopsies were conducted locally, while
five were performed at an outside donor institution, and
two performed at our institution following whole brain
shipment from the donor site.

Results

Processing and handling of postmortem DIPG
specimens greatly affects the feasibility and results of
downstream molecular analyses. Rapid processing of
specimens is essential to ensure preservation of high
quality mRNA, DNA, protein, and other biologically
relevant molecules. One of the major factors contributing
to rapid specimen procurement is the availability of a local
pathologist, and a suitable autopsy facility for specimen
procurement.
However, we have often encountered situations
where either a pathologist was not available or
coordinating with a pathology team was not possible due
to lack of time. Thus, two protocols were devised: i) a
protocol for local specimen procurement, and ii) a protocol

Inclusion Criteria
Inclusion criteria were as follows: i) patients of
any age with clinical and radiologic diagnosis of diffuse
intrinsic pontine glioma, ii) patients with high-grade
gliomas originating in the brainstem, iii) patients with
focal gliomas of the brainstem.

Brain Autopsy Procedure

Procured DIPG Specimens and Related Clinical
Characteristics
A total of 19 brain tumor patients or their families
expressed interest in postmortem tissue donation from
2010-2014. Of these, 16 (84%) underwent the procurement
procedure. Patient age ranged from 5 to 12 years and
autopsy was performed from 5 to 48 hours from the time
of death. In 12 (73%) cases, the request for autopsy was
initiated by the patient’s family, while the remainder of

Fig.1: Postmortem processing of brainstem and cerebellum. Postmortem brainstem and cerebellum were sectioned into axial
sections (a) sectioning through the midbrain, pons and medulla (dotted lines) and through the cerebellum. Alternative sections were either
fresh frozen (b) or formalin fixed (c). Fixed samples were then cut into sub-blocks, sections were produced and processed for histological
staining (d).
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12741

Oncotarget

for the shipment of whole brain for processing at receiving
institute. Both protocols describe a method for collection
of CSF and whole brain specimens, including specimen
processing for acquisition of frozen and formalin fixed
tissue, and specimens for cell culture purposes. The two
protocols are discussed in detail below.

The cerebral hemispheres are also processed in
entirety, starting with the frontal lobe and ending at the
occipital lobe, producing roughly 12 coronal sections (Fig.
2a). Each section is imaged, and alternative sections are
processed for flash freezing or formalin fixation (Fig. 2b).

Protocol for the shipment of whole brain for
processing at receiving institute

Protocol for Brain Processing and Procurement
Our protocol (Online Resource 1) details specimen
processing performed at our center and external
sites, where both an autopsy room and pathologist
were available. The protocol details procurement and
processing of ventricular cerebrospinal fluid (CSF),
cerebral hemispheres, and brainstem tissue. Briefly, lateral
ventricular CSF is obtained using a sterile needle, and
CSF is processed for storage and subsequent molecular
analysis. The brainstem along with cerebellum were
removed en bloc from the cerebral hemispheres, and these
two anatomical specimens are processed as fresh frozen
and formalin fixed specimens as described below.
The brainstem is sectioned axially into ten portions
starting at the midbrain and ending at the cervicomedullary
junction (Fig. 1). Cerebellum is sectioned along with
the brainstem. Each section is imaged, measured and
alternated for preservation as fresh frozen or formalin
fixed specimens. This provides matched formalin fixed
specimens for each frozen section, suitable for molecular
studies including mRNA, protein, microRNA and DNA
analysis. Fixed specimens are embedded in paraffin,
sectioned for mounting on slides, and hematoxylin and
eosin staining. Consequently, a neuropathologist evaluates
these stained slides for histopathological analysis, and
tumor grading.

We developed a second protocol for cases where
tissue procurement at the local site was not possible (e.g.
unavailability of pathology team or other resources). This
protocol (Online Resource 2) describes specimen (whole
brain and CSF) processing for overnight shipment to the
receiving institution. The receiving institution can then
process the whole brain as described above.

Standardized Specimen
Documentation

Procurement

and

All specimens were procured and processed as
described in Methods. The procurement method ensured
standardization of the autopsy and specimen acquisition
process, allowing correlation of autopsied materials
with clinical data. For example, due to the accurate
characterization and documentation of sections obtained
from brainstem, we were able to correlate frozen tumor
samples with representative images on MR studies (Fig.
3a, b). Moreover, this standardized specimen procurement
method can facilitate specimen tracking in cases where
original autopsy material is shared among various
institutions (Fig. 3c, d).

Fig.2: Postmortem processing of whole cortex. Upon removal and processing of the brainstem and cerebellum, whole brain was

sectioned into coronal slices (a). Sectioning was performed from frontal (section 1, panel b) through the occipital lobe (section 12, panel b)
to generate between 10 to 12 slices and imaged for future reference (b). Alternative sections were either frozen or fixed in formalin.
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Histological Studies of Cortical Sections Obtained
by Standardized Autopsy Procedure

ideal for molecular analysis including mRNA, protein,
and genomic profiling; whereas FFPE samples are more
suitable for accurate histological studies. This combination
of tissue preparations allows for comprehensive analysis
of obtained specimens.

Our standardized autopsy protocol allows for
comprehensive molecular characterization of precious
DIPG tissue specimens, by ensuring each fresh frozen
specimen is also represented by formalin fixed paraffin
embedded (FFPE) sections (Fig. 4). Frozen specimens are

Generation of murine Model of DIPG Using
Postmortem Specimens
Fresh autopsy specimens were stored in DMSO as
described in Materials and Methods.. DMSO preserved
specimens (10 hour post mortem) from one patient were
orthotopically injected into the brainstem of ten-day old
(p10) mice (n=10). Injections were performed according
to established methods [7] by hand at 2 mm posterior to
the bregma at the midline position. Seventy percent of
injected mice resulted in infiltrating pontine (Fig. 5a,b) or
cortical (data not shown) tumors positive for proliferative
marker Ki67 (Fig. 5c ). These tumors were also positive
for human mitochondrial protein as detected by MAB1273
antibody (Fig. 5d). Tumors showed reduced Histone 3 K27
trimethylation staining (Fig. 5e) but increased Histone
3 K27 mutation (Fig. 5f) indicating their human cell of
origin.

Discussion
Fig.3: Correlation of histological studies with clinical
data. Sagittal (a) and axial (b) MR images from a DIPG

Diffuse intrinsic pontine glioma is a fatal childhood
cancer with no effective treatment. Surgical resection
is not possible, and tissue biopsies are rarely obtained.
Postmortem donation is therefore a major source
of biological specimens for studying DIPG. Recent
identification of Histone 3 K27M mutation and other

patient were correlated with autopsied brainstem tissue. The
transverse line (a) indicates the plane represented by formalin
fixed specimen shown in panel c. Each specimen was clearly
labeled (red markings) and cut into sub-blocks. Panel d shows a
representative of one sub-block (asterisk in c) that was processed
for H&E staining.

Fig.4: Detailed histological studies of brainstem tissue is enhanced by matched FFPE sections for each frozen specimen.

The Cerebral cortex and Brainstem were sectioned and each alternative section was processed as FFPE or fresh frozen. Alternative FFPE
specimens were stained for H&E and studied by a pathologist. Histopathology of the frozen section was then judged by the histological
readings of the two surrounding FFPE samples. Punch cores were then obtained from the middle frozen section for downstream molecular
studies including RNA and DNA analyses.
www.impactjournals.com/oncotarget
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unique genomic aberrations driving DIPG were made
possible by the availability of autopsied and rare biopsied
specimens for molecular analysis [2, 4, 5, 8, 9]. Since

molecular studies of these specimens are largely affected
by procurement procedures, ongoing collaborative efforts
to centralize and standardize postmortem DIPG specimen
procurement and analysis are underway. Furthermore,
we show that up to 73% of donations were initiated by
patient’s family. This remarkable willingness to donate
tissue specimens demonstrates that families in the DIPG
community already perceive a potential to improve
the understanding of DIPG through tissue donation
for research. In light of this observation, it is important
to inform all families about the possibility to donate
specimens for research, and to emphasize the significant
impact this gift can have on accelerating scientific
discoveries to improve DIPG care and treatment. Such
measures can potentially increase participation in postmortem donation. In our experience, the optimal time to
approach the patient’s family for discussing postmortem
donation is after completion of radiation treatment, when
the patient’s clinical symptoms are stabilized. We describe
a comprehensive protocol to allow systematic, effective
procurement of postmortem DIPG specimens for further
molecular studies.
Recent studies of DIPG tissue specimens, and our
own observations (unpublished data), suggest tumor
extension and local invasion beyond the neuroanatomical
confines of the brainstem [10]. We therefore find it prudent
to procure and process the brain in its entirety for future
comprehensive studies. Recent studies have indicated that
WHO-based histological grading does not predict clinical
outcome for DIPG [11]. Overall survival of H3.3 K27M
mutant DIPG patients with grade II tumors was similar to
those with grade IV GBM tumors (also with H3.3 K27M
mutation). Comparative studies of biopsied and autopsied

Fig.5: Orthotopic injection of DMSO preserved cells
results in diffuse pontine tumors. (a) Mice were injected
orthotopically in brainstem with cells stored in DMSO. Mice that
showed signs of tumor development were sacrificed, brains were
fixed and processed for histological studies. H&E staining showed
tumor formation in pons (P) as judged by (b) hypercellularity,
(c) proliferation marker Ki67, (d) human mitochondrial protein
MAB1273 (e) histone 3 K27 trimethylation, and (f) histone 3
K27M mutation.

Fig.6: Ventricular extended tumor retains characteristics of primary pontine tumor. Histological staining were performed
using the primary pontine (a and b) and extended ventricular (c-f) tumor specimens. H&E staining showed highly cellular tumors (WHO
IV). Both pontine (b) and extended ventricular (d) tumors were positive for Ki67, (e) while the ventricular retained high expression of
histone 3 mutation and (f) reduced histone 3 trimethylation.
www.impactjournals.com/oncotarget
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brain specimens have shown that despite mRNA and
protein degradation, autopsied specimens are a reliable
source for biological analysis [12-14]. Such comparisons,
however, are not often feasible for DIPG due to the lack
of upfront biopsies. However, Zarghooni and colleagues
[15] analyzed nine postmortem and two surgical samples
and showed no significant differences in gene expression
profile across surgical and postmortem specimens. We and
others have published molecular studies of postmortem
specimens and shown the reliability of these specimens
for proteomics, genomics, and mRNA studies [2, 16].
Furthermore, DIPG specimens are routinely shared
between collaborative institutions. In many instances, these
specimens have been labeled as “pontine tumor,” with
the precise anatomic tumor location not clearly indicated
(e.g. dorsal versus ventral, rostral versus caudal). The
precise anatomic origin of acquired specimens is critical
for data comparison and validation assays. Our method of
imaging each fresh frozen and FFPE specimen facilitates
more accurate specimen tracking and characterization to
ensure data are generated from tumor regions with similar
histological characteristics (Fig. 3c). We found that the
xenograft line closely represents primary human tumor by
expressing histone 3 K27M mutant phenotype. Expression
of human mitochondrial proteins in the murine tumor is
further confirmation of the model’s fidelity and suitability
for preclinical testing (Fig. 5a-f). In light of the recent
debates on the extent of DIPG infiltration into surrounding
structures, we suggest molecular analysis of mouse models
created by orthotopic injection of primary and extended
tumors obtained from the same patient. Our postmortem
specimen procurement method allows for this, as well
as for studying the mechanism of tumor extension. Our
preliminary studies show that extended tumor retains the
proliferative and histone 3 mutation status of the primary
tumor (Fig. 6). However, further studies are prudent to
address whether histone 3 K27M mutation is preserved
along the path of tumor infiltration in cases of tumor
extension, and whether additional mutations are gained
along the path of migration.
Another essential question to address is the nature
of the direct tumor extension (anatomic continuity) or
metastasis (spread to distant sites within the central
nervous system) in DIPG. To our best knowledge,
currently, there are no published studies establishing
whether DIPG spreads by direct extension or metastasis
throughout the CNS. The methods proposed here could
potentially shed light on this issue, and provide insight
into the infiltrative vs. metastatic nature of DIPG.
In summary, we believe that implementation of the
protocol described here by the scientific community could
standardize the method of acquisition and processing of
rare DIPG tumor specimens. Adoption of these methods
could facilitate standardized, efficient analysis of these
precious specimens across research consortia ensuring
optimal utilization. This practice could therefore help to
www.impactjournals.com/oncotarget

clarify the biological and infiltrative nature of DIPG, and
facilitate the standardization of DIPG postmortem studies.

Materials and Methods
Human Specimen Collection
All local specimens were collected in accordance
with Children’s National Health System (CNHS)
Institutional Review Board (IRB) approvals (IRB# 1339,
#463 and #747). Specimens from sites outside CNHS
were obtained in accordance to the local IRB approvals.
Autopsy consent was obtained in cases where an IRB
protocol did not exist, or the decision to donate was made
during or after patient’s death.

Specimen Procurement and Processing for Cell
Culture and Orthotopic Injection
In order to obtain specimens for cell culture or
orthotopic injection, tissue (~0.25cm thick with a surface
of ~0.5cm X 0.5cm) from the brainstem and supratentorial
cortex were collected into Hibernate A media, which was
then transferred on ice to a BSL 2 hood. Tissue was placed
in a petri dish containing HBSS-Hepes, and minced into
tiny pieces using a sterile No. 10 scalpel. After pelleting
by centrifugation (200 g for 5 min), a portion of the
tissue pellet was frozen in complete media containing
10% DMSO to use with orthotopic injections at a later
date. The remaining pellet was subjected to enzymatic
digestion to prepare a single cell suspension. Digestion
buffer containing DNase I (250 units/ml) and Collagenase
IV (1mg/ml) in HBSS-Hepes was added to the tissue pellet
and incubated in 37°C water bath for 15 min. Digestion
was stopped by diluting the sample with HBSS-Hepes, and
cells were pelleted by centrifugation. The cell pellet was
then incubated with 1 ml of RBC lysis buffer at 37°C for
1 min. RBC digestion was inactivated by adding HBSSHepes and cells were collected by centrifugation. The cell
pellet was then resuspended in 15 ml of HBSS-Hepes
and filtered through a 70 micron cell strainer to remove
undissociated tissue and debris. Cells were then counted
using trypan blue exclusion assay, and divided into two
fractions before processing for cell culture, or orthotopic
injection into mice. For culturing, cells were pelleted
and plated in Neurobasal A medium containing 50% of
DMEM F12 and supplemented with B27 without vitamin
A (2%), human-basic FGF (20 ng/mL), human-EGF (20
ng/mL), human PDGF-AB (20 ng/mL), and heparin (10
ng/mL). For immediate orthotopic mice injections cells
were collected as a pellet and maintained on ice. For
injection of cells from DMSO frozen tissue, samples were
thawed quickly and resuspended in HBSS-Hepes. After
passing through a 70 µm cell strainer, cells were counted
12745
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and collected by centrifugation as a pellet followed by
orthotopic injection as described below.
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NOD SCID gamma (NSG) mice ranging from 2
to 10 days old were used for orthotopic injection of cells
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subjected to hypothermia-induced anesthesia. Injection
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IACUC protocol # 292-12-05.
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